Trial Profile
Therapeutic effects of direct renin inhibitor in end stage kidney disease patients with maintenance hemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Angiotensin receptor antagonists
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2015 New trial record